Bicalutamide
Who holds supplier records for Bicalutamide? 14 organisations hold a current record for Bicalutamide: an active US FDA Type II Drug Master File or a CEP. A further 15 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), Netherlands (2), Italy (1), Spain (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Bicalutamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/bicalutamide
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Bicalutamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AARTI PHARMALABS LIMITEDIndiaCEPActive DMF 20502 · latest filing May 2007
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 18496 · latest filing Jul 2005
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 25730 · latest filing Jan 2012
- TAPI NL BVNetherlandsCEPActive DMF 17008 · latest filing Dec 2003
- OLON SPAItaly Company GMP cert on recordActive DMF 19624 · latest filing Jul 2006
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 24690 · latest filing May 2011
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 20263 · latest filing Feb 2007
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainActive DMF 21103 · latest filing Nov 2007
- Cipla LimitedIndiaCEP Company GMP cert on recordInactive DMF 18723 · latest filing Aug 2005
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordInactive DMF 18792 · latest filing Sept 2005
- KEKULE PHARMA LTDIndiaCEPInactive DMF 20785 · latest filing Aug 2007
- MAC CHEM PRODUCTS INDIA PVT LTDCEPInactive DMF 26355 · latest filing Aug 2012
- NetherlandsCEP Company GMP cert on record
- SHAANXI DASHENG PHARMACEUTICAL TECH CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Bicalutamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| EXCELLA GMBH & CO. KG Feucht | DE | CEP 2012-270 - Rev 04 Bicalutamide, Milled, Milled (Z) | Oct 2026 | Inspected Apr 2026 Germany |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2012-254 - Rev 04 Bicalutamide, Form-H1 | Oct 2026 | — |
| MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai | IN | CEP 2019-329 - Rev 02 Bicalutamide | Apr 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2012-303 - Rev 02 Bicalutamide | Apr 2026 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | CEP 2012-283 - Rev 02 Bicalutamide, Crystalline form-I, micronised and non-micronised | Jul 2025 | Inspected Aug 2026 Slovakia |
| SYNTHON B.V. Nijmegen | NL | CEP 2012-153 - Rev 03 Bicalutamide, Micronised | Sept 2024 | Inspected May 2024 Netherlands |
| SHAANXI DASHENG PHARMACEUTICAL TECH CO., LTD. Xi’an | CN | CEP 2017-174 - Rev 02 Bicalutamide | Nov 2023 | — |
| AARTI PHARMALABS LIMITED Mulund (W), Mumbai | IN | R1-CEP 2012-223 - Rev 01 Bicalutamide | Nov 2022 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2014-191 - Rev 00 Bicalutamide | Aug 2021 | — |
| KEKULE PHARMA LIMITED Hyderabad | IN | R1-CEP 2012-413 - Rev 00 Bicalutamide | Jul 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (15)
Organisations whose Type II DMFs for Bicalutamide are no longer active. These show a past filing, not current supply.
Show all 15 historical records
- India · Inactive DMF 24922 · filed Jun 2011
- MYLAN LABORATORIES LTDInactive DMF 24670 · filed Feb 2011
- SIGNA SA DE CVInactive DMF 22784 · filed May 2009
- Germany · Inactive DMF 21670 · filed May 2008
- India · Inactive DMF 21333 · filed Sept 2007
- India · Inactive DMF 20099 · filed Dec 2006
- India · Inactive DMF 19782 · filed Sept 2006
- India · Inactive DMF 19587 · filed Jun 2006
- TAI HENG INDUSTRY CO LTDInactive DMF 19546 · filed Apr 2006
- Italy · Inactive DMF 19410 · filed Apr 2006
- Japan · Inactive DMF 19311 · filed Mar 2006
- Hungary · Inactive DMF 18776 · filed Sept 2005
- India · Inactive DMF 18374 · filed May 2005
- CF PHARMA LTDInactive DMF 18141 · filed Mar 2005
- China · Inactive DMF 17878 · filed Dec 2004
Overview
Bicalutamide is a non-steroidal antiandrogen medication used primarily to treat prostate cancer. It works by inhibiting the action of male hormones in the prostate, slowing the growth of prostate cancer cells.
Chemical identity
- IUPAC name
- N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
- Canonical SMILES
- CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
- InChIKey
- LKJPYSCBVHEWIU-UHFFFAOYSA-N
- Synonyms
- Casodex API, casodex, ici 176,334, ici-176334, ici176,334-1, nsc-759816
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Androgen Receptor Inhibitor
- Mechanism of action
- Androgen Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Bicalutamide?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Bicalutamide: AARTI PHARMALABS LIMITED (India), Hetero Labs Limited (India), MSN Laboratories Private Limited (India), TAPI NL BV (Netherlands), OLON SPA (Italy), SHILPA PHARMA LIFESCIENCES LTD (India), Sun Pharmaceutical Industries Limited (India) and UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (Spain), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Bicalutamide Drug Master Files are active?
AARTI PHARMALABS LIMITED (DMF 20502), Hetero Labs Limited (DMF 18496), MSN Laboratories Private Limited (DMF 25730), TAPI NL BV (DMF 17008), OLON SPA (DMF 19624), SHILPA PHARMA LIFESCIENCES LTD (DMF 24690), Sun Pharmaceutical Industries Limited (DMF 20263) and UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (DMF 21103). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Bicalutamide records mean?
15 organisations have only inactive Type II DMFs for Bicalutamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Bicalutamide have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Bicalutamide on the EDQM register, including EXCELLA GMBH & CO. KG Feucht (DE), HETERO LABS LIMITED Hyderabad (IN), MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL), MSN LABORATORIES PRIVATE LIMITED Kardanur Village (IN) and SYNTHON B.V. Nijmegen (NL) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Bicalutamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Bicalutamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.